COVID-19 testing remains a critical barrier to reopening the U.S. economy.
Ten testing updates:
- HHS overrides states, lets all pharmacists give COVID-19 tests
New HHS guidance overrides state and local rules that prevented pharmacists from administering COVID-19 diagnostic tests. - FDA approves another at-home COVID-19 test
The FDA granted emergency use authorization to a second COVID-19 diagnostic test that allows patients to collect samples using nasal swabs. - FDA reviewing accuracy of Abbott coronavirus test
Abbott's COVID-19 diagnostic test may return false negatives, the FDA warned. - LabCorp, Quest expand COVID-19 testing
LabCorp and Quest Diagnostics both said they've ramped up their COVID-19 testing capacity. - How feds will divvy up $11B to states for COVID-19 testing
The White House has revealed how it plans to distribute $11 billion from the CARES ACT to support state testing. - CMS allows pharmacies to bill Medicare for COVID-19 tests
CMS implemented a temporary policy that allows pharmacies to bill Medicare for COVID-19 tests, a move that could increase the number of pharmacies able to offer diagnostic testing. - FDA gives emergency OK to Abbott's COVID-19 antibody test
The FDA granted emergency use authorization for Abbott Laboratories' new COVID-19 antibody test. - FDA approves first antigen, saliva COVID-19 tests
The FDA authorized two new types of diagnostic COVID-19 tests this week, the first antigen test and the first at-home test that uses saliva samples. - FDA clears development, sale of at-home COVID-19 tests
The FDA posted new guidelines that allow manufacturers to develop and market COVID-19 test kits that could be used by people at home and mailed to any lab in the country, a move the agency hopes will significantly increase U.S. testing capacity. - FDA tightens standards for COVID-19 antibody tests
The FDA strengthened rules for COVID-19 antibody tests after public health officials raised concerns over the quality of the tests, which were allowed on the market without FDA review.